CANCERLINQ DISCOVERY Trademark

Trademark Overview


On Thursday, January 5, 2017, a trademark application was filed for CANCERLINQ DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the CANCERLINQ DISCOVERY trademark a serial number of 87290547. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 14, 2024. This trademark is owned by American Society of Clinical Oncology, Inc.. The CANCERLINQ DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing physicians and other healthcare providers information in the field of neoplastic disease prevention, screening, diagnosis and treatment; providing patient information in the field of neoplastic diseases

Providing medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; application service provider featuring software for use in aggregating and analyzing health care and medical data; Scientific and medical research, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare data and preparing reports in connection therewith
cancerlinq discovery

General Information


Serial Number87290547
Word MarkCANCERLINQ DISCOVERY
Filing DateThursday, January 5, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 14, 2024
Registration Number5376694
Registration DateTuesday, January 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements


Pseudo MarkCANCER LINK DISCOVERY
Goods and ServicesProviding physicians and other healthcare providers information in the field of neoplastic disease prevention, screening, diagnosis and treatment; providing patient information in the field of neoplastic diseases
Goods and ServicesProviding medical and scientific research information in the field of neoplastic diseases to medical and scientific researchers; providing medical and scientific research information in the field of clinical trials for neoplastic diseases; application service provider featuring software for use in providing on-line medical databases; application service provider featuring software for use in aggregating and analyzing health care and medical data; Scientific and medical research, namely, collecting, comparing, and analyzing of patient-level medical and clinical healthcare data and preparing reports in connection therewith

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 13, 2017
Primary Code042
First Use Anywhere DateMonday, October 2, 2017
First Use In Commerce DateMonday, October 2, 2017

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 13, 2017
Primary Code044
First Use Anywhere DateMonday, October 2, 2017
First Use In Commerce DateMonday, October 2, 2017

Trademark Owner History


Party NameCANCERLINQ LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressCAMBRIDGE, MA 02138

Party NameAmerican Society of Clinical Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAlexandria, VA 22314

Party NameAmerican Society of Clinical Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAlexandria, VA 22314

Party NameAmerican Society of Clinical Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAlexandria, VA 22314

Trademark Events


Event DateEvent Description
Wednesday, February 8, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, January 9, 2017NEW APPLICATION ENTERED
Friday, January 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 14, 2017NOTICE OF PSEUDO MARK E-MAILED
Tuesday, January 31, 2017ASSIGNED TO EXAMINER
Wednesday, February 8, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, February 8, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 8, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, February 9, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 16, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, November 16, 2017USE AMENDMENT FILED
Friday, December 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, December 2, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 5, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 6, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 9, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 9, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 9, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, January 31, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, May 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 14, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, May 7, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, May 7, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 7, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 7, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 7, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 7, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 14, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED